Health And Medicine

In a large-scale study of electronic health records, Vanderbilt University Medical Center investigators have determined the prevalence of functional seizures and characterized comorbidities associated with them. Read More

Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated aging. Read More

Researchers at Vanderbilt University Medical Center and Case Western Reserve University in Cleveland have been awarded a five-year, $3.3 million grant by the National Cancer Institute to apply artificial intelligence (AI) to help customize treatment for oral cancer patients. Read More

Moderna, remdesivir, AstraZeneca. VUMC’s experts have played an integral role in the development of these marquee COVID-19 therapeutics behind the scenes.  Read More

The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances. Read More

A team of Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma. Read More

This spring in the U.S., there were widespread delays in elective health care procedures and screenings. Read More

In March, Vanderbilt University Medical Center leaders established a command center on campus to address the myriad issues that the Medical Center would face in the coming days, weeks and months as the COVID-19 pandemic encroached on Tennessee, then Nashville and finally on campus. Read More

Craig Lindsley, William K. Warren, Jr. Chair in Medicine and university professor of chemistry, pharmacology and biochemistry, has been named editor in chief of the "Journal of Medicinal Chemistry." His appointment will begin Jan. 1.  Read More

Chancellor Daniel Diermeier will host a special presentation with coronavirus expert Dr. Mark R. Denison on Monday, Dec. 14, from 11 a.m. to noon Central time. Denison’s presentation, “Preparing for the COVID-19 Pandemic ... for 36 Years,” will explore why COVID-19 emerged, his lab’s discoveries, and where we go from here. Read More

David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read More

Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read More

The Vanderbilt School of Medicine Basic Sciences has won continued funding from the National Institutes of Health for its Initiative for Maximizing Student Diversity program supporting the success of biomedical graduate students from underrepresented backgrounds. Read More

Women diagnosed with early-onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology. Read More

When in-person research activities at Vanderbilt were put on hold in mid-March due to the COVID-19 pandemic, nursing professor Sheila Ridner’s steadfast commitment to patients ensured that their care did not suffer. Read More

Modernized endoscopic system blends robotics and magnetic coupling to improve medical procedures, starting with colonoscopies. Read More

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.  Read More

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center. Read More

Further research by biochemistry professors Charles Sanders and  Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read More

Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read More